EP 3 134 432 B1 relates to MND promoter chimeric antigen receptors (CARs), and use of these compositions to effectively treat various cancers or tumours.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The board decided that the OD had correctly exercised its discretion in admitting the late filed CPA=D16 in the procedure.